[go: up one dir, main page]

AU2002361185A1 - Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent - Google Patents

Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent

Info

Publication number
AU2002361185A1
AU2002361185A1 AU2002361185A AU2002361185A AU2002361185A1 AU 2002361185 A1 AU2002361185 A1 AU 2002361185A1 AU 2002361185 A AU2002361185 A AU 2002361185A AU 2002361185 A AU2002361185 A AU 2002361185A AU 2002361185 A1 AU2002361185 A1 AU 2002361185A1
Authority
AU
Australia
Prior art keywords
dimethylamino
phenol
propyl
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002361185A
Inventor
Elmar Friderichs
Ulrich Jahnel
Wolfgang Strassburger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Chemie Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH, Chemie Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2002361185A1 publication Critical patent/AU2002361185A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002361185A 2001-12-21 2002-12-20 Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent Abandoned AU2002361185A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10163421A DE10163421A1 (en) 2001-12-21 2001-12-21 Use of (+) - (1S, 2S) -3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol as an anti-emetic
DE10163421.8 2001-12-21
PCT/EP2002/014636 WO2003053427A1 (en) 2001-12-21 2002-12-20 Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent

Publications (1)

Publication Number Publication Date
AU2002361185A1 true AU2002361185A1 (en) 2003-07-09

Family

ID=7710471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002361185A Abandoned AU2002361185A1 (en) 2001-12-21 2002-12-20 Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent

Country Status (3)

Country Link
AU (1) AU2002361185A1 (en)
DE (1) DE10163421A1 (en)
WO (1) WO2003053427A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12194022B2 (en) 2010-03-11 2025-01-14 Acacia Pharma Limited Use of amisulpride as an anti-emetic
US12329740B2 (en) 2017-02-10 2025-06-17 Acacia Pharma Limited Rescue treatment of post operative nausea and vomiting

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005013726A1 (en) * 2005-03-22 2006-09-28 Grünenthal GmbH Transdermal therapeutic system for transdermal application of opioid containing analgesics, especially using a plaster for application to permit long-term, pain-free application
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
RU2589692C2 (en) * 2010-06-15 2016-07-10 Грюненталь Гмбх Pharmaceutical combination for pain treatment
EP2736501B1 (en) 2011-07-29 2017-12-20 Grünenthal GmbH Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (en) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-phenyl-3-dimethylamino-propane compounds with pharmacological activity
DE10109763A1 (en) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmaceutical salts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12194022B2 (en) 2010-03-11 2025-01-14 Acacia Pharma Limited Use of amisulpride as an anti-emetic
US12329740B2 (en) 2017-02-10 2025-06-17 Acacia Pharma Limited Rescue treatment of post operative nausea and vomiting

Also Published As

Publication number Publication date
DE10163421A1 (en) 2003-07-31
WO2003053427A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
WO2004105722A8 (en) A formulation for chemical peeling
AU2002360759A1 (en) Polyether carbamate compounds, compositions containing such compounds, and methods related thereto
AU2002353132A1 (en) Resveratrol analogues
NO20034527L (en) 3,7-diazabicyclo (3,3,1) formulations as antiarrhythmic compounds
AUPR878201A0 (en) New compounds
AU2002334406A1 (en) Polishing composition
HK1042036A1 (en) Calcilytic compounds
AU2002361185A1 (en) Use of (+)-(1s,2s)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol as anti-emetic agent
AU2002359914A1 (en) Blade sharpener
AU2002322326A1 (en) Tolterodine metabolites
AU2002307456A1 (en) Resource localization
AU2002331972A1 (en) 3,4-methylenedioxy-substituted chalcones as therapeutic agents
NO20034528D0 (en) 3,7-diazabicyclo (3,3,1) formulations as antiarrhythmic compounds
AU2002356930A1 (en) Partially fluorinated naphthyl-based borates
AU2001271933A1 (en) Alpha,alpha-dibromo-alpha-chloro-acetophenones as synthons
AU2001250279A1 (en) Use of naphthindazole-4,9-quinones as antiparasitic agents
AU2002331281A1 (en) New uses for 2-amino-2-propane-1,3-diols
AU2002364178A1 (en) Ownership of part-physical, part-virtual devices
AU2002252646A1 (en) Cyclohexylphenyl vasopressin agonists
AU2002329500A1 (en) New sulfonamide derivatives as d3-receptor agonists
AU2002238736A1 (en) Anaesthetic formulation comprising articaine
AU2002228465A1 (en) Finishing agent
AU2002230320A1 (en) Impregnating agent
AU2002244943A1 (en) Remedies for vesical hyperactivity
AU2002317385A1 (en) Compounds for use as surfactants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase